Slager David Mark 13D and 13G filings for Vascular Biogenics Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-01 4:20 pm Purchase | 2022-01-24 | 13G | Vascular Biogenics Ltd. VBLT | Slager David Mark | 101,545 5.130% | 101,545![]() (New Position) | Filing |